Roche's Tamiflu approved by US FDA for preventative use in children
ZURICH (AFX) - Roche Holding AG said its Tamiflu drug has been approved by
the US Food and Drug Administration (FDA) for preventing influenza in children
aged 1-12.
Previously it was approved in the US for prevention in adolescents (age 13
years and older) and adults only.
The drug received a positive opinion for prevention in children in
Switzerland and Europe last week.
afx.zurich@afxnews.com
scs/jfr